Retinal vascular occlusion affects the eye, specifically the retina. The retina is the light-sensitive layer of tissue that lines the back of your eye. It’s covered with special cells called rods and ...

The FDA approved an updated label for Vabysmo for the treatment of macular edema following retinal vein occlusion beyond 6 ...

The FDA’s decision to extend the labeled duration of faricimab use in RVO beyond 6 months primarily reflects accumulated evidence supporting its continued efficacy and safety over longer treatment ...

They're not all directly related to your eye, either.

Obstructive sleep apnea (OSA) was associated with a notably higher risk of developing retinal vein occlusion across different demographic groups, with the greatest increase observed in people of ...

MK-8748 combines direct Tie2 pathway activation with VEGF inhibition, targeting persistent vascular leakage and vessel ...

Please provide your email address to receive an email when new articles are posted on . A literature search identified 70 eyes with retinal vasculitis or vascular occlusion following brolucizumab for ...

– Additional U.S. label update across indications includes information on rare post-marketing reports of retinal vasculitis and/or retinal vascular occlusion; reporting rate is in line with other ...

A new study explores the relationship between subclinical atherosclerosis and retinal vascular impairment (conditions affecting blood circulation behind the eye) in people with systemic lupus ...

In a groundbreaking discovery that sounds like science fiction but is absolutely real, researchers have found that your eyes contain hidden signals that could predict your risk of having a stroke.